Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Arnesen

Showing results (51-60 of 164) with videos related to

Pageof 17
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1978
The ethanol gelation test in pregnancyC Eika, H Arnesen, H C Godal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 10, 1995
[Fat-soluble vitamins in clinical practice]H Arnesen, P M Sandset, J Eritsland
Thrombosis Research|January 1, 1994
Stability of plasma PAI-I at room temperatureI Seljeflot, A H Haaland, H Arnesen
Thrombosis Research|October 15, 1986
Changes in fibrinolytic capacity and lipoprotein pattern during long-term treatment with warfarinH Arnesen, P Smith, E B Aspelund
Scandinavian Journal of Haematology|January 1, 1973
The influence of fibrinogen degradation products on the reptilase-time of plasmaH Arnesen, P Kierulf, H C Godal
Thrombosis Et Diathesis Haemorrhagica|June 28, 1973
The effect of fibrinogen degradation products on plasmin activityM Myśliwiec, H Arnesen, H C Godal
Vascular Pharmacology|April 15, 2015
A brief review on high on-aspirin residual platelet reactivityA A Pettersen, H Arnesen, I Seljeflot
Thrombosis Research|June 15, 1990
Warfarin has no negative impact on fibrinolysisP Smith, H Arnesen, T Opstad, et al.
Acta Medica Scandinavica|January 1, 1978
A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolismB Ly, H Arnesen, H Eie, et al.
European Journal of Heart Failure|March 14, 2001
Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarctionM Hurlen, T Hole, I Seljeflot, et al.
Pageof 17

Showing results (51-60 of 164) with videos related to

Sort By:
Pageof 17
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1978
The ethanol gelation test in pregnancyC Eika, H Arnesen, H C Godal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 10, 1995
[Fat-soluble vitamins in clinical practice]H Arnesen, P M Sandset, J Eritsland
Thrombosis Research|January 1, 1994
Stability of plasma PAI-I at room temperatureI Seljeflot, A H Haaland, H Arnesen
Thrombosis Research|October 15, 1986
Changes in fibrinolytic capacity and lipoprotein pattern during long-term treatment with warfarinH Arnesen, P Smith, E B Aspelund
Scandinavian Journal of Haematology|January 1, 1973
The influence of fibrinogen degradation products on the reptilase-time of plasmaH Arnesen, P Kierulf, H C Godal
Thrombosis Et Diathesis Haemorrhagica|June 28, 1973
The effect of fibrinogen degradation products on plasmin activityM Myśliwiec, H Arnesen, H C Godal
Vascular Pharmacology|April 15, 2015
A brief review on high on-aspirin residual platelet reactivityA A Pettersen, H Arnesen, I Seljeflot
Thrombosis Research|June 15, 1990
Warfarin has no negative impact on fibrinolysisP Smith, H Arnesen, T Opstad, et al.
Acta Medica Scandinavica|January 1, 1978
A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolismB Ly, H Arnesen, H Eie, et al.
European Journal of Heart Failure|March 14, 2001
Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarctionM Hurlen, T Hole, I Seljeflot, et al.
Pageof 17